Lion Point Capital, LP Milestone Pharmaceuticals Inc. Transaction History
Lion Point Capital, LP
- $9.73 Million
- Q1 2025
A detailed history of Lion Point Capital, LP transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Lion Point Capital, LP holds 548,806 shares of MIST stock, worth $817,720. This represents 4.51% of its overall portfolio holdings.
Number of Shares
548,806
Previous 1,025,806
46.5%
Holding current value
$817,720
Previous $2.42 Million
81.86%
% of portfolio
4.51%
Previous 18.72%
Shares
11 transactions
Others Institutions Holding MIST
# of Institutions
52Shares Held
16.8MCall Options Held
341KPut Options Held
70.3K-
Black Rock Inc. New York, NY4.97MShares$7.41 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$3.73 Million0.03% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.45MShares$2.16 Million1.35% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.43MShares$2.13 Million0.56% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.14MShares$1.69 Million0.74% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $44.7M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...